Literature DB >> 9024796

beta-amyloid-induced endothelial necrosis and inhibition of nitric oxide production.

E T Sutton1, G R Hellermann, T Thomas.   

Abstract

Deposits of amyloid beta-peptide (A beta) in senile plaques and cerebral blood vessels is the prominent feature of Alzheimer's disease (AD), regardless of genetic predisposition. The cellular origin of cerebral deposits of A beta or its precise role in the neurodegenerative process has not been established. Recently we demonstrated a novel action of beta-amyloid on blood vessels--vasoactivity and endothelial damage through superoxide radicals. Since endothelial dysfunction is associated with vascular degenerative diseases, we examined the direct action of A beta on endothelial cells in culture. Cells treated with A beta displayed characteristics of necrotic cell death which was prevented by the free radical scavenging enzyme superoxide dismutase. Stimulation of endothelial nitric oxide (NO) production by the calcium ionophore, A23187, or bradykinin was inhibited by beta-amyloid. We conclude that an imbalance of NO and oxygen radicals may mediate the A beta-induced endothelial damage on endothelial cells in culture and may also contribute to a variety of pathophysiological conditions associated with aging: hypertension, cerebral ischemia, vasospasm, or stroke.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024796     DOI: 10.1006/excr.1996.3440

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats.

Authors:  Charleine Zussy; Anthony Brureau; Brice Delair; Stephane Marchal; Emeline Keller; Guy Ixart; Gaelle Naert; Johann Meunier; Nathalie Chevallier; Tangui Maurice; Laurent Givalois
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

2.  Selective astrocytic endothelin-1 overexpression contributes to dementia associated with ischemic stroke by exaggerating astrocyte-derived amyloid secretion.

Authors:  Victor K L Hung; Patrick K K Yeung; Angela K W Lai; Maggie C Y Ho; Amy C Y Lo; Kevin C Chan; Ed X K Wu; Stephen S M Chung; Chi W Cheung; Sookja K Chung
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

3.  Cerebral amyloid angiopathy: progressive disruption of the neurovascular unit.

Authors:  Gregory J Zipfel; Henry Han; Andria L Ford; Jin-Moo Lee
Journal:  Stroke       Date:  2008-12-08       Impact factor: 7.914

Review 4.  Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?

Authors:  Rory J Kelleher; Roy L Soiza
Journal:  Am J Cardiovasc Dis       Date:  2013-11-01

Review 5.  Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System.

Authors:  Jonathan Janssens; Harmonie Etienne; Sherif Idriss; Abdelkrim Azmi; Bronwen Martin; Stuart Maudsley
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-01       Impact factor: 5.555

6.  Increased pulmonary arteriolar tone associated with lung oxidative stress and nitric oxide in a mouse model of Alzheimer's disease.

Authors:  Andrew M Roberts; Rekha Jagadapillai; Radhika A Vaishnav; Robert P Friedland; Robert Drinovac; Xingyu Lin; Evelyne Gozal
Journal:  Physiol Rep       Date:  2016-09

7.  Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer's Disease.

Authors:  Hasan Turkez; Ivana Cacciatore; Lisa Marinelli; Erika Fornasari; Mehmet Enes Aslan; Kenan Cadirci; Cigdem Yuce Kahraman; Ozge Caglar; Abdulgani Tatar; Giuseppe Di Biase; Ahmet Hacimuftuoglu; Antonio Di Stefano; Adil Mardinoglu
Journal:  Biomolecules       Date:  2021-01-19

8.  Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-β peptide injection in rats.

Authors:  Charleine Zussy; Anthony Brureau; Emeline Keller; Stéphane Marchal; Claire Blayo; Brice Delair; Guy Ixart; Tangui Maurice; Laurent Givalois
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

9.  Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.

Authors:  Justin Paul; Sidney Strickland; Jerry P Melchor
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

10.  Histidyl-Proline Diketopiperazine Isomers as Multipotent Anti-Alzheimer Drug Candidates.

Authors:  Hasan Turkez; Ivana Cacciatore; Mehmet Enes Arslan; Erika Fornasari; Lisa Marinelli; Antonio Di Stefano; Adil Mardinoglu
Journal:  Biomolecules       Date:  2020-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.